1. Established an organizational structure in accordance with cGMP requirements. 
2. Key positions are held by professionals with experience in drug manufacturing and quality management. 
3. Quality management system in place, and documents such as quality manuals, management systems, SOPs, SMPs, and related records are prepared in accordance with quality management system.
4. Daily quality management work is strictly implemented in accordance with quality management documents.
5. Quality control is designed in accordance with pharmacopoeia requirements, including functional rooms such as microbiological testing labs (including sterile rooms, positive control rooms, and microbiological limit rooms), instrument rooms, physical and chemical constant testing labs, stability testing labs, and sample retention rooms. It is equipped with instruments and equipment such as HPLC, GC, melting point apparatus, polarimeter, UV, analytical balance, biosafety cabinets, ultra-clean workbenches, high-pressure sterilizers, and incubators, fully meeting drug inspection and control requirements.

Upon the successful completion of the Phase 1 construction, Longzen presently commands an annual production capacity of 350 tons of alpha-Lipoic acid, 572 tons of other drug substances, 30 million bottles of injectables, and 2 billion tablets (capsules) of solid drug products. Shandong Longzen Pharmaceutical Co., Ltd. represents a modern pharmaceutical company that seamlessly integrates product research and development, manufacturing, sales and marketing.

Longzen is continuously investing ~US$30 million to continue expanding production capacity, constructing 8 intermediate production lines, 4 API clean area production lines, and 1 multi-functional injection production line, and transforming each workshop and section into an intelligent, automated, and standardized production workshop. Longzen is committed to ongoing investments of approximately US$30 million, aimed at further augmenting production capacity. This endeavor involves the establishment of 8 production lines, 4 API production lines, and 1 injectable production line. Additionally, we are in the process of modernizing each workshop and department, enhancing them to intelligent, automated, and standardized production facilities.

1. Equipped with refining-drying-packing workshop (for API) and cleanliness level is D
2. 89 reactors (1,000L-10,000L) in total 
3. 4 glass-lined crystallization kettle (2,000L-10,000L)
4. 1 stainless steel distillation column (12,000L)
5. 1 stainless steel distillation column (10,000L)
6. 4 Glass-Lined Steel Column (1,500L, for high vacuum high temperature)
7. Equipped with centrifuge, double-tapered Rotary Vacuum, pulverizer
8. Equipped with 30T/H purified water unit, brine unit (salt temperature -35°C)
9. Equipped with ethylene glycol cooling system (temperature 10-15°C), circulating water system
10. Equipped with nitrogen generator, vacuum pumps and air compressors, etc.

1. High-temperature reaction: temperature control range 0℃ to 200℃, heated with heat transfer oil.
2. Low-temperature reaction: temperature control range -20℃ to -70℃, cooled with liquid nitrogen.
3. High-temperature and high-vacuum distillation: temperature control range 0℃ to 200℃, ultimate vacuum 10Pa.
4. High-pressure hydrogenation reaction: pressure range 0.1 to 10MPa.

1. Invested more than US$20 million
2. Has already built a set of modern environmental protection unit and sewage treatment implementation
3. Waste gas treatment capacity: 40000Nm³/h
4. Total wastewater treatment capacity: 500m³/d
5. Equipped with three effect evaporator, RTO incinerator, falling film absorption column
6. Equipped with alkali washing tower, water washing tower, atomization tower
7. Equipped with quench tower, high altitude chimney
8. Equipped with automatic waste gas treatment control system and supporting sewage treatment tank etc.